Literature DB >> 12135968

Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.

K M Bradley1, V T O'Sullivan, N D W Soper, Z Nagy, E M-F King, A D Smith, B J Shepstone.   

Abstract

Reductions in regional cerebral perfusion, particularly in the posterior temporo-parietal lobes, are well recognized in Alzheimer's disease. We set out to correlate perfusion changes, using (99m)Tc-HMPAO single photon emission tomography (SPET), with the pathological stage of Alzheimer's disease. The 'Braak stage' of the distribution of neurofibrillary pathology in post-mortem brains was used to classify SPET scans taken in life from a mixed (dementia and control) elderly population into the entorhinal stage (n = 23 subjects), limbic stage (n = 30 subjects) and neocortical stage (n = 36 subjects) Alzheimer's disease pathology. The SPET scans were then registered to a common, standard Talaraich space, and single template scans produced for each pathological stage. Comparison of these templates revealed an evolution in the pattern of reduction in regional perfusion. Additional comparisons were performed using earlier SPET scans obtained 5 years before death. For comparisons between templates, a threshold of 10% perfusion change was chosen so as to be clinically relevant as well as statistically significant. Reduced perfusion appears between the entorhinal and limbic stages in the anterior medial temporal lobe, subcallosal area, posterior cingulate cortex, precuneus and possibly the supero-anterior aspects of the cerebellar hemispheres. Large posterior temporo-parietal perfusion defects then appear between the limbic and neocortical stages, before finally large frontal lobe perfusion defects. The time course of these perfusion defects appears relatively long, suggesting that perfusion changes may have scope to be a diagnostic aid in staging Alzheimer's disease in life. The reduction in anterior medial temporal lobe perfusion may have future relevance on modern high resolution SPET and PET systems and also perfusion-type MRI sequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135968     DOI: 10.1093/brain/awf185

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  65 in total

1.  Sensory evoked and event related oscillations in Alzheimer's disease: a short review.

Authors:  Görsev G Yener; Erol Başar
Journal:  Cogn Neurodyn       Date:  2010-10-21       Impact factor: 5.082

2.  Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study.

Authors:  Giorgos Karas; Philip Scheltens; Serge Rombouts; Ronald van Schijndel; Martin Klein; Bethany Jones; Wiesje van der Flier; Hugo Vrenken; Frederik Barkhof
Journal:  Neuroradiology       Date:  2007-10-23       Impact factor: 2.804

3.  Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer's disease.

Authors:  Lorena R R Gianotti; Gabriella Künig; Pascal L Faber; Dietrich Lehmann; Roberto D Pascual-Marqui; Kieko Kochi; Ursula Schreiter-Gasser
Journal:  Psychopharmacology (Berl)       Date:  2008-04-30       Impact factor: 4.530

4.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

Review 5.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 6.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

7.  Imaging cerebral blood flow in the cognitively normal aging brain with arterial spin labeling: implications for imaging of neurodegenerative disease.

Authors:  Charles Lee; Oscar L Lopez; James T Becker; Cyrus Raji; Weiying Dai; Lewis H Kuller; H Michael Gach
Journal:  J Neuroimaging       Date:  2009-03-09       Impact factor: 2.486

8.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.

Authors:  Lisa Mosconi; Rachel Mistur; Remigiusz Switalski; Wai Hon Tsui; Lidia Glodzik; Yi Li; Elizabeth Pirraglia; Susan De Santi; Barry Reisberg; Thomas Wisniewski; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

9.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI.

Authors:  Michael D Greicius; Gaurav Srivastava; Allan L Reiss; Vinod Menon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

10.  Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

Authors:  Renaud La Joie; Audrey Perrotin; Louisa Barré; Caroline Hommet; Florence Mézenge; Méziane Ibazizene; Vincent Camus; Ahmed Abbas; Brigitte Landeau; Denis Guilloteau; Vincent de La Sayette; Francis Eustache; Béatrice Desgranges; Gaël Chételat
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.